Daptomycin

Part of speech: noun

Definitions

  1. A cyclic lipopeptide antibiotic used to treat Gram-positive bacterial infections by disrupting cell membrane function and causing rapid bacterial death; administered intravenously to combat resistant strains such as MRSA and VRE; utilized primarily for skin infections and bacteremia
  2. An antibacterial agent characterized by a cyclic peptide structure linked to a lipid tail, effective against resistant Gram-positive bacteria through membrane depolarization and inhibition of essential ion transport; given via injection to treat severe infections including those of the skin and bloodstream
  3. A clinical antibiotic compound that targets Gram-positive bacteria by binding to their membranes and inducing depolarization, thereby halting bacterial growth and promoting cell death; employed intravenously to manage complicated skin infections and bloodstream infections caused by resistant bacteria

Etymology: A relatively recent addition to the lexicon of medical science, this term emerged in the late 20th century as the name for a powerful antibiotic. It was coined during the development of a novel drug derived from natural sources, specifically from a bacterium belonging to the genus Streptomyces. The name itself reflects the conventions of pharmaceutical nomenclature, designed to convey certain aspects of the molecule's structure and activity while ensuring distinctiveness. The root "mycin" is a common suffix in antibiotic names, tracing back to the Greek "mykes," meaning fungus. Historically, many antibiotics were isolated from fungi or fungus-like bacteria, and this suffix became a hallmark of such agents. The prefix "dapt-" is less transparent but likely relates to the drug's mechanism or origin. It is believed to be derived from "dapto-" or "dapt-," a construction used to suggest binding or attachment, which aligns with the antibiotic's mode of action involving disruption of bacterial membranes. Introduced into clinical use in the early 2000s, this antibiotic represented a new class called lipopeptides. Unlike traditional antibiotics that target bacterial cell walls or protein synthesis, it acts by inserting into bacterial membranes, causing rapid depolarization and cell death. The name's construction reflects this innovative approach, incorporating elements that hint at the compound's lipid-based mechanism and peptide nature. The formation of the name follows a pattern common in pharmaceutical chemistry, blending Greek and Latin roots with suffixes that indicate the compound's class and biological source. Such names are crafted by teams of chemists and marketers to be unique, pronounceable, and indicative of the drug's characteristics. This naming practice ensures clarity among healthcare professionals and supports regulatory approval processes. Overall, this term encapsulates a modern intersection of microbiology, chemistry, and medicine, representing both a specific molecule and the broader scientific endeavor to combat resistant bacterial infections through novel therapeutic agents.

Synonyms: antibiotic, lipopeptide antibiotic